Perinatal Administration Of Short-Chain Fructooligosaccharides In Order To Prevent Metabolic Disorders Linked To An Unbalanced Diet At Adult Age

Patent No. EP3600336 (titled "Perinatal Administration Of Short-Chain Fructooligosaccharides In Order To Prevent Metabolic Disorders Linked To An Unbalanced Diet At Adult Age") was filed by Beghin Meiji on Mar 30, 2018. The application was issued on Jan 1, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SUDZUCKERSep 24, 2025GLEISS GROSSE SCHRELL UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3600336

BEGHIN MEIJI
Application Number
EP18722117A
Filing Date
Mar 30, 2018
Status
Granted And Under Opposition
Nov 29, 2024
Publication Date
Jan 1, 2025